![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
1. 2(s),4(s),5(s),7(s)-n-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-(4-methoxy-3-(3-methoxypropoxy)phenyl)octanamid Hemifumarate
2. Aliskiren
3. Cgp 060536b
4. Cgp-060536b
5. Cgp060536b
6. Rasilez
7. Spp100
8. Tekturna
1. 173334-58-2
2. Tekturna
3. Aliskiren Fumarate
4. Aliskiren (hemifumarate)
5. Enviage
6. Riprazo
7. Sprimeo
8. Spp-100b
9. Chebi:53777
10. C8a0p8g029
11. Nsc-759185
12. Cgp 60536
13. Aliskirenfumarate
14. (2s,4s,5s,7s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide;(e)-but-2-enedioic Acid
15. Cgp60536b
16. Bis(2s,4s,5s,7s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methyl-2-(1-methylethyl)nonanamide) (2e)-but-2-enedioate
17. Aliskiren Fumarate [usan]
18. Unii-c8a0p8g029
19. Aliskiren Fumarate [usan:jan]
20. Tekturna (tn)
21. Cgp-60536
22. Aliskiren Hemifumarate- Bio-x
23. Schembl187762
24. Aliskiren (as Fumarate)
25. Aliskiren Fumarate (jan/usan)
26. Aliskiren Fumarate [jan]
27. Chembl3545059
28. Cgp-60536b
29. Aliskiren Fumarate [mart.]
30. Aliskiren Hemifumarate [mi]
31. Aliskiren Fumarate [who-dd]
32. Mfcd10566724
33. S2199
34. Aliskiren Hemifumarate [vandf]
35. Akos015896419
36. Ccg-270658
37. Cs-0729
38. Ks-1395
39. Nsc 759185
40. S12129
41. (2s,4s,5s,7s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonanamide Hemifumarate
42. Ba164146
43. Hy-12177
44. Aliskiren Hemifumarate [orange Book]
45. Sw222231-1
46. D06412
47. Rasitrio Component Aliskiren Hemifumarate
48. Tekamlo Component Aliskiren Hemifumarate
49. Valturna Component Aliskiren Hemifumarate
50. Amturnide Component Aliskiren Hemifumarate
51. Rasilamlo Component Aliskiren Hemifumarate
52. Aliskiren Hemifumarate Component Of Rasitrio
53. Aliskiren Hemifumarate Component Of Tekamlo
54. Aliskiren Hemifumarate Component Of Valturna
55. Raprazo-hct Component Aliskiren Hemifumarate
56. Rasilez-hct Component Aliskiren Hemifumarate
57. Sprimeo-hct Component Aliskiren Hemifumarate
58. Aliskiren Hemifumarate Component Of Amturnide
59. Aliskiren Hemifumarate Component Of Rasilamlo
60. Tekturna Hct Component Aliskiren Hemifumarate
61. Aliskiren Hemifumarate Component Of Raprazo-hct
62. Aliskiren Hemifumarate Component Of Rasilez-hct
63. Aliskiren Hemifumarate Component Of Sprimeo-hct
64. Q27124205
65. Aliskiren Hemifumarate Component Of Tekturna Hct
66. (?s,?s,?s,?s)-?-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-?-hydroxy-4-methoxy-3-(3-methoxypropoxy)-?,?-bis(1-methylethyl)benzeneoctanamide Hemifumarate
67. 5-amino-n-(3-amino-2,2-dime-3-oxoprop)-4-oh-2-isoprop-7-[4-meo-3-(3-meo-propoxy)benzyl]-8-methylnonanamide Hemifumarate
68. Benzeneoctanamide, Delta-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-alpha,zeta-bis(1-methylethyl)-, (alphas,gammas,deltas,zetas)-, (2e)-2-butenedioate (2:1) (salt)
69. Bis((2s,4s,5s,7s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonanamide) Fumarate
70. Bis{(2s,4s,5s,7s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide} (2e)-but-2-enedioate
Molecular Weight | 1219.6 g/mol |
---|---|
Molecular Formula | C64H110N6O16 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 40 |
Exact Mass | 1218.79783144 g/mol |
Monoisotopic Mass | 1218.79783144 g/mol |
Topological Polar Surface Area | 367 Ų |
Heavy Atom Count | 86 |
Formal Charge | 0 |
Complexity | 836 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Tekturna |
PubMed Health | Aliskiren (By mouth) |
Drug Classes | Antihypertensive |
Drug Label | Tekturna contains aliskiren hemifumarate, a renin inhibitor, that is provided as tablets for oral administration. Aliskiren hemifumarate is chemically described as (2S,4S,5S,7S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-me... |
Active Ingredient | Aliskiren hemifumarate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 150mg base; eq 300mg base |
Market Status | Prescription |
Company | Novartis |
2 of 2 | |
---|---|
Drug Name | Tekturna |
PubMed Health | Aliskiren (By mouth) |
Drug Classes | Antihypertensive |
Drug Label | Tekturna contains aliskiren hemifumarate, a renin inhibitor, that is provided as tablets for oral administration. Aliskiren hemifumarate is chemically described as (2S,4S,5S,7S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-me... |
Active Ingredient | Aliskiren hemifumarate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 150mg base; eq 300mg base |
Market Status | Prescription |
Company | Novartis |
Treatment of essential hypertension.
Treatment of essential hypertension.
Treatment of essential hypertension
Treatment of essential hypertension
C09XA02
C09XA02
C09XA02
C09XA02